Skip to content

Evaluation of PerioMonitor for Detection of Oral Inflammatory (OI) in Human Subjects in Medical Practice

Evaluation of PerioMonitor for Detection of Oral Inflammatory (OI) in Human Subjects in Medical Practice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06570044
Enrollment
86
Registered
2024-08-26
Start date
2024-07-30
Completion date
2025-05-01
Last updated
2025-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Inflammation

Brief summary

The purpose of the study is to evaluate the usability of PerioMonitor™ in a medical clinic environment and to evaluate the effectiveness of a referral system from physicians to dentists for patients identified with high oral inflammation. PerioMonitor™ is an In Vitro Diagnostic (IVD) device intended as an aid in the detection of oral inflammation in individuals of 18 years and older. This test is intended for use at point-of-care (POC) sites by health care professionals (e.g., physicians, nurses, medical assistants, dentists, dental hygienists, and dental assistants).

Interventions

DIAGNOSTIC_TESTPerioMonitor

Collection of oral rinse specimen and perform the PerioMonitor test as per the method described in the instructions for use

Sponsors

Oral Science International Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* subject fluent in English * subject has signed the ICF

Exclusion criteria

* subject with altered mental status/inability to provide informed consent or follow the procedure of the Study * Previous enrolment into the current Study * Patients with known severe oral diseases such as oral cancer

Design outcomes

Primary

MeasureTime frameDescription
Ratio (%) of valid tests/performed testsDay 0The ratio of valid PerioMonitor tests (with no issue reported) over the total number of tests performed
Ease of Test PerformanceDay 0The Ease-of-Test Performance will be evaluated by a 5-question questionnaire
Use errorDay 0Any issue encountered with collection of specimens and/or test reading. The overall ratio (%) of tests with use errors as well as the ratio per operator will be measured
Comfort to participantsDay 0Comfort to participants with sample collection (Yes/No). The Overall ratio (%) of discomfort ('No') as well as the ratio per operator will be measured.

Secondary

MeasureTime frameDescription
Proportion (%) participants referred to a Dental Specialist12-MonthThe recommended course of action further to completion of the PerioMonitor test will be documented with a 4-item report form. The ratio (%) of participants referred to a dental specialist visit as the recommended course of action will be calculated.
Proportion (%) of compliant participants with the recommended visit to a Dental Specialist6-MonthVisits to a Dental Specialist will be monitored by querying participants' electronic medical records or by direct contact (email or phone) and data (visit date, treatment) will be documented in a report form. The ratio (%) of participants who completed a visit to a Dental Specialist over all participants referred to a dental specialist visit as the recommended course of action will be calculated.
Proportion (%) of participants referred to a Dental Specialist6-MonthThe recommended course of action further to completion of the PerioMonitor test will be documented with a 4-item report form. The ratio (%) of participants referred to a dental specialist visit as the recommended course of action will be calculated.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026